Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | ACP3 | P15309 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 2/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 3/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | FDPS | P14324 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17223190 | 0.84 | CA2 (0.48) | ALDH1A1TSHRLMNAACP3CA2 | |
| SCHEMBL7826685 | 0.84 | ALDH1A1 (0.43) | ALDH1A1TSHRLMNAACP3CYP1A2 | |
| SCHEMBL17223228 | 0.82 | ALDH1A1 (0.42) | ALDH1A1TSHRLMNAACP3CYP1A2 | |
| Hydrochloric Acid SCHEMBL10912515 | 0.82 | ALDH1A1 (0.42) | ALDH1A1TSHRLMNAACP3CYP1A2 | |
| SCHEMBL1726840 | 0.80 | CYP2A6 (0.45) | ALDH1A1TSHRCYP1A2CYP2A6TRPA1 | |
| SCHEMBL2342981 | 0.77 | TRPA1 (0.48) | ALDH1A1TSHRLMNAACP3TRPA1 | |
| SCHEMBL10929953 | 0.76 | ALDH1A1 (0.46) | ALDH1A1TSHRACP3CYP1A2CYP2A6 | |
| SCHEMBL21621579 | 0.76 | HPGD (0.43) | ALDH1A1TSHRCYP1A2CYP2A6TRPA1 | |
| Phosphoric Acid SCHEMBL30528979 | 0.76 | TRPA1 (0.52) | ALDH1A1TSHRLMNAACP3CYP1A2 | |
| Phosphoric Acid SCHEMBL27222307 | 0.76 | TRPA1 (0.52) | ALDH1A1TSHRLMNAACP3CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9822425-B2 | Processes for recovering metals from aqueous solutions | CYTEC TECHNOLOGY CORP. (US) | 2017-11-21 | — | — | US | disclosed |
| US-9670240-B2 | Cyclic phosphinate derivatives and method of preparing the same | KNU-INDUSTRY COOPERATION FOUNDATION (KR) | 2017-06-06 | — | — | US | disclosed |
| US-20170022229-A1 | NOVEL CYCLIC PHOSPHINATE DERIVATIVES AND METHOD OF PREPARING THE SAME | KNU-INDUSTRY COOPERATION FOUNDATION (KR) | 2017-01-26 | — | — | US | disclosed |
| US-9487547-B2 | Cyclic phosphinate derivatives and method of preparing the same | KNU-INDUSTRY COOPERATION FOUNDATION (KR) | 2016-11-08 | — | — | US | disclosed |
| US-20150315219-A1 | NOVEL CYCLIC PHOSPHINATE DERIVATIVES AND METHOD OF PREPARING THE SAME | KNU-INDUSTRY COOPERATION FOUNDATION (KR) | 2015-11-05 | — | — | US | disclosed |
| US-20150135903-A1 | PROCESSES FOR RECOVERING METALS FROM AQUEOUS SOLUTIONS | CYTEC TECHNOLOGY CORP. (US) | 2015-05-21 | — | — | US | disclosed |
| US-8968698-B2 | Processes for recovering metals from aqueous solutions | CYTEC TECHNOLOGY CORP. (US) | 2015-03-03 | — | — | US | disclosed |
| US-20140127095-A1 | PROCESSES FOR RECOVERING METALS FROM AQUEOUS SOLUTIONS | CYTEC TECHNOLOGY CORP. (US) | 2014-05-08 | — | — | US | disclosed |
| US-8328900-B2 | Processes for recovering metals from aqueous solutions | CYTEC TECHNOLOGY CORP. (US) | 2012-12-11 | — | — | US | disclosed |
| EP-2451985-A2 | PROCESSES FOR RECOVERING METALS FROM AQUEOUS SOLUTIONS | Cytec Technology Corporation (US) | 2012-05-16 | — | — | EP | disclosed |
| WO-2011005736-A2 | PROCESSES FOR RECOVERING METALS FROM AQUEOUS SOLUTIONS | CYTEC TECHNOLOGY CORP. (US) | 2011-01-13 | — | — | WO | disclosed |
| US-20110005354-A1 | PROCESSES FOR RECOVERING METALS FROM AQUEOUS SOLUTIONS | CYTEC TECHNOLOGY CORP. (US) | 2011-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170022229-A1 | NOVEL CYCLIC PHOSPHINATE DERIVATIVES AND METHOD OF PREPARING THE SAME | PPOX, PNPO, PRDX5 | ALDH1A1 3102/4885TSHR 2557/4885LMNA 3913/4885 |
| US-20150315219-A1 | NOVEL CYCLIC PHOSPHINATE DERIVATIVES AND METHOD OF PREPARING THE SAME | PPOX, PNPO, PRDX5 | ALDH1A1 3102/4885TSHR 2557/4885LMNA 3913/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.